These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 6861280)
1. Pretreatment of normal human fibroblasts and human colon carcinoma cells with MNNG allows chloroethylnitrosourea to produce DNA interstrand crosslinks not observed in cells treated with chloroethylnitrosourea alone. Zlotogorski C; Erickson LC Carcinogenesis; 1983; 4(6):759-63. PubMed ID: 6861280 [TBL] [Abstract][Full Text] [Related]
2. Specific DNA repair mechanisms may protect some human tumor cells from DNA interstrand crosslinking by chloroethylnitrosoureas but not from crosslinking by other anti-tumor alkylating agents. Gibson NW; Zlotogorski C; Erickson LC Carcinogenesis; 1985 Mar; 6(3):445-50. PubMed ID: 3978757 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment of human colon tumor cells with DNA methylating agents inhibits their ability to repair chloroethyl monoadducts. Zlotogorski C; Erickson LC Carcinogenesis; 1984 Jan; 5(1):83-7. PubMed ID: 6690090 [TBL] [Abstract][Full Text] [Related]
4. Transfection of DNA from a chloroethylnitrosourea-resistant tumor cell line (MER+) to a sensitive tumor cell line (MER-) results in a tumor cell line resistant to MNNG and CNU that has increased O-6-methylguanine-DNA methyltransferase levels and reduced levels of DNA interstrand crosslinking. Yarosh DB; Barnes D; Erickson LC Carcinogenesis; 1986 Sep; 7(9):1603-6. PubMed ID: 3742731 [TBL] [Abstract][Full Text] [Related]
5. The effects of pretreatment of human tumour cells with MNNG on the DNA crosslinking and cytotoxicity of mitozolomide. Gibson NW; Erickson LC Br J Cancer; 1985 Aug; 52(2):251-8. PubMed ID: 4027167 [TBL] [Abstract][Full Text] [Related]
6. DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Erickson LC; Laurent G; Sharkey NA; Kohn KW Nature; 1980 Dec; 288(5792):727-9. PubMed ID: 7005689 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of cytotoxicity by 3-aminobenzamide in DNA repair-deficient human tumor cell lines following exposure to methylating agents or anti-neoplastic drugs. Babich MA; Day RS Carcinogenesis; 1988 Apr; 9(4):541-6. PubMed ID: 3356063 [TBL] [Abstract][Full Text] [Related]
8. alpha-Difluoromethylornithine effects on nitrosourea-induced cytotoxicity and crosslinking in a methylation excision repair positive (MER+) human cell line. Ducore JM Biochem Pharmacol; 1987 Jul; 36(13):2169-74. PubMed ID: 3111477 [TBL] [Abstract][Full Text] [Related]
9. Expression of human O6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents. Wu ZN; Chan CL; Eastman A; Bresnick E Cancer Res; 1992 Jan; 52(1):32-5. PubMed ID: 1727384 [TBL] [Abstract][Full Text] [Related]
10. Relationship of DNA repair phenotypes of human fibroblast and tumor strains to killing by N-methyl-N'-nitro-N-nitrosoguanidine. Scudiero DA; Meyer SA; Clatterbuck BE; Mattern MR; Ziolkowski CH; Day RS Cancer Res; 1984 Mar; 44(3):961-6. PubMed ID: 6692418 [TBL] [Abstract][Full Text] [Related]
11. Exogenous O6-methylguanine inhibits adduct removal and sensitizes human cells to killing by the chemical carcinogen N-methyl-N'-nitro-N-nitrosoguanidine. Babich MA; Day RS Mutat Res; 1987 Nov; 184(3):245-54. PubMed ID: 3670328 [TBL] [Abstract][Full Text] [Related]
13. Synergistic killing of virus-transformed human cells with interferon and N-methyl-N'-nitro-N-nitrosoguanidine. Babich MA; Day RS Carcinogenesis; 1989 Feb; 10(2):265-8. PubMed ID: 2463881 [TBL] [Abstract][Full Text] [Related]
14. DNA damage and cytotoxicity of 2-chloroethyl (methylsulfonyl)methanesulfonate (NSC 338947) produced in human colon carcinoma cells with or without methylating agent pretreatment. Hartley JA; Gibson NW Cancer Res; 1986 Aug; 46(8):3871-5. PubMed ID: 3015378 [TBL] [Abstract][Full Text] [Related]
15. Analysis of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced DNA damage in tumor cell strains from Japanese patients and demonstration of MNNG hypersensitivity of Mer xenografts in athymic nude mice. Watatani M; Ikenaga M; Hatanaka T; Kinuta M; Takai S; Mori T; Kondo S Carcinogenesis; 1985 Apr; 6(4):549-53. PubMed ID: 3986962 [TBL] [Abstract][Full Text] [Related]
16. Adaptive resynthesis of O6-methylguanine-accepting protein can explain the differences between mammalian cells proficient and deficient in methyl excision repair. Waldstein EA; Cao EH; Setlow RB Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5117-21. PubMed ID: 6957853 [TBL] [Abstract][Full Text] [Related]
17. Human tumor cell strains defective in the repair of alkylation damage. Day RS; Ziolkowski CH; Scudiero DA; Meyer SA; Mattern MR Carcinogenesis; 1980 Jan; 1(1):21-32. PubMed ID: 22282976 [TBL] [Abstract][Full Text] [Related]
18. [Effect of pretreatment with N-methyl-N-nitrosourea or streptozotocin on the cytotoxicity and the induction of sister chromatid exchanges in human and rodent brain tumor cells treated with chloroethylnitrosourea]. Tokuda K Hokkaido Igaku Zasshi; 1992 Jul; 67(4):462-74. PubMed ID: 1427592 [TBL] [Abstract][Full Text] [Related]
19. Comparison of mutation spectra induced by N-ethyl-N-nitrosourea in the hprt gene of Mer+ and Mer- diploid human fibroblasts. Yang JL; Lee PC; Lin SR; Lin JG Carcinogenesis; 1994 May; 15(5):939-45. PubMed ID: 8200099 [TBL] [Abstract][Full Text] [Related]
20. Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains. Day RS; Ziolkowski CH; Scudiero DA; Meyer SA; Lubiniecki AS; Girardi AJ; Galloway SM; Bynum GD Nature; 1980 Dec; 288(5792):724-7. PubMed ID: 6256643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]